NASDAQ · WVE
Wave Life Sciences, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for WVE has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.33 | $-0.26 | $-0.37 | 7 |
| Mar 2027 | $-0.30 | $-0.26 | $-0.34 | 4 |
| Jun 2027 | $-0.32 | $-0.27 | $-0.34 | 4 |
| Sep 2027 | $-0.31 | $-0.28 | $-0.33 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · MarketBeat · Fintel- RTTNews · Oct 27, 3:28 PM EDTBiotech Stocks Move Higher: ZURA Surges 21%, PLUR Gains 13%, WVE Rises 7%, KNSA Advances(RTTNews) – Shares of several biotech companies moved higher following quarterly financial results, clinical pipeline updates and strategic developments. Kiniksa Pharmaceuticals raised its 2026 ARCALYST revenue outlook, Pluri announced a U.S. commercialization partnership with ZE
- The Motley Fool · Oct 27, 2:58 PM EDTWave Life Sciences (WVE) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Oct 27, 1:05 PM EDTWAVE Life Sciences Q3 Earnings Call HighlightsGolden Cross Alert: 3 Stocks With Major Upside PotentialWAVE Life Sciences (NASDAQ:WVE) reported higher third-quarter revenue and a wider net loss as it increased investment in clinical programs spanning obesity, alpha-1 antitrypsin deficiency and liver disease. Revenue for the
- Fintel · Oct 27, 10:54 AM EDTWave Life Sciences Ltd. Reports Third Quarter 2026 Financial ResultsWave Life Sciences Ltd. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline. The company reported cash, cash equivalents, and marketable securities of $431.0 million as of September 30, 2026, which is expect
- Zacks · Oct 27, 7:40 AM EDTWave Life Sciences (WVE) Reports Q3 Loss, Tops Revenue EstimatesWave Life Sciences (WVE) delivered earnings and revenue surprises of +11.77% and +342.29%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Oct 27, 7:37 AM EDTWave Life Sciences Ltd. Q3 Sales Increase(RTTNews) – Wave Life Sciences Ltd. (WVE) announced Loss for third quarter of -$61.91 million
- MarketBeat · Oct 21, 11:02 PM EDTWAVE Life Sciences Highlights Obesity Data, FDA-Aligned RNA Editing PathGolden Cross Alert: 3 Stocks With Major Upside PotentialWAVE Life Sciences (NASDAQ:WVE) outlined progress across its obesity-focused siRNA program and RNA editing pipeline during a Chardan discussion, with President and CEO Paul Bolno emphasizing the company’s chemistry platform,
- Zacks · Oct 21, 9:00 AM EDTAnalysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out forGlaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- RTTNews · Oct 2, 12:13 PM EDTWeekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data(RTTNews) – The week brought a fresh round of developments across the biotech and pharma landscape, with companies advancing new therapies through regulatory milestones, clinical studies, strategic deals and corporate activity. Key updates spanned oncology, rare diseases, cardiov
- RTTNews · Oct 1, 10:44 AM EDTWave Gains FDA Support For WVE-006 Registrational Pathway In AATD(RTTNews) – On Thursday, Wave Life Sciences (WVE) said it reached alignment with the FDA on key aspects of the registrational pathway for WVE-006, an investigational RNA editing therapy for alpha-1 antitrypsin deficiency (AATD).
- RTTNews · Sep 30, 8:05 AM EDTWave Life Science Advance Liver-Focused SiRNA Program With GSK; Stock Up(RTTNews) – A liver-focused RNA medicine candidate from Wave Life Sciences (WVE) is moving into GSK's development pipeline, triggering a $12 million milestone payment to Wave under their research collaboration.
- Zacks · Sep 28, 9:57 AM EDT4 RNA Therapeutics Stocks Leading the Next Wave of InnovationRNA therapeutics are gaining momentum as Alnylam, Ionis, Wave Life Sciences and Arcturus advance innovative treatments targeting a range of diseases.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Wave Life Sciences, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.